Unravelling the role of BK polyomavirus genetic variants in viral pathogenicity and clearance in kidney transplant recipients
Fragment-based drug design of antivirals targeting the polyomavirus capsid and flaviviral NS3-helicase
Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary Human renal cells
Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements
A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients